Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Vascular Permeability Drives Susceptibility to Influenza Infection in a Murine Model of Sickle Cell Disease.

Karlsson EA, Oguin TH, Meliopoulos V, Iverson A, Broadnax A, Yoon SW, Pestina T, Thomas P, Webby R, Schultz-Cherry S, Rosch JW.

Sci Rep. 2017 Mar 3;7:43308. doi: 10.1038/srep43308.

2.

Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.

Bennewitz MF, Jimenez MA, Vats R, Tutuncuoglu E, Jonassaint J, Kato GJ, Gladwin MT, Sundd P.

JCI Insight. 2017 Jan 12;2(1):e89761. doi: 10.1172/jci.insight.89761.

3.

Sickle cell disease: wheeze or asthma?

Cohen RT, Klings ES, Strunk RC.

Asthma Res Pract. 2015 Dec 8;1:14. doi: 10.1186/s40733-015-0014-2. eCollection 2015. Review.

4.

Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research.

Sadreameli SC, Kopp BT, Creary SE, Eakin MN, McGrath-Morrow S, Strouse JJ.

Int J Environ Res Public Health. 2016 Nov 12;13(11). pii: E1131. Review.

5.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.

Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, Lévy Y, Galactéros F, Godeau B.

EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.

6.
7.

The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.

DeBaun MR, Strunk RC.

Lancet. 2016 Jun 18;387(10037):2545-53. doi: 10.1016/S0140-6736(16)00145-8. Review.

8.

ATS Core Curriculum 2016: Part III. Pediatric Pulmonary Medicine.

Boyer D, Thomson CC, Cohen R, Rao D, Dell S, Rayment J, Wang R, Dy FJ, Wambach J, Tam-Williams J, Simon D, Price E, Oermann CM, Singh A, Rettig JS, Duncan ED, Baker CD, Liptzin DR, Moore PE.

Ann Am Thorac Soc. 2016 Jun;13(6):955-66. doi: 10.1513/AnnalsATS.201602-097CME. No abstract available.

9.

Splenectomy in Patients with Sickle Cell Disease in Tabuk.

Ghmaird A, Alnoaiji MM, Al-Blewi S, Zaki S, El-Lewi A, Ahmad N.

Open Access Maced J Med Sci. 2016 Mar 15;4(1):107-11. doi: 10.3889/oamjms.2016.034. Epub 2016 Feb 29.

10.

Preventive Care Delivery to Young Children With Sickle Cell Disease.

Bundy DG, Muschelli J, Clemens GD, Strouse JJ, Thompson RE, Casella JF, Miller MR.

J Pediatr Hematol Oncol. 2016 May;38(4):294-300. doi: 10.1097/MPH.0000000000000537.

11.

Bedside Lung Ultrasound During Acute Chest Syndrome in Sickle Cell Disease.

Razazi K, Deux JF, de Prost N, Boissier F, Cuquemelle E, Galactéros F, Rahmouni A, Maître B, Brun-Buisson C, Mekontso Dessap A.

Medicine (Baltimore). 2016 Feb;95(7):e2553. doi: 10.1097/MD.0000000000002553.

12.

Novel insights in the management of sickle cell disease in childhood.

Iughetti L, Bigi E, Venturelli D.

World J Clin Pediatr. 2016 Feb 8;5(1):25-34. doi: 10.5409/wjcp.v5.i1.25. eCollection 2016 Feb 8. Review.

13.

Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes?

Creary SE, Chisolm DJ, Koch TL, Zigmont VA, Lu B, O'Brien SH.

Pediatr Blood Cancer. 2016 May;63(5):844-7. doi: 10.1002/pbc.25894. Epub 2016 Jan 21.

14.

Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Noubouossie D, Key NS, Ataga KI.

Blood Rev. 2016 Jul;30(4):245-56. doi: 10.1016/j.blre.2015.12.003. Epub 2015 Dec 24. Review.

PMID:
26776344
15.

Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13.

Eiymo Mwa Mpollo MS, Brandt EB, Shanmukhappa SK, Arumugam PI, Tiwari S, Loberg A, Pillis D, Rizvi T, Lindsey M, Jonck B, Carmeliet P, Kalra VK, Le Cras TD, Ratner N, Wills-Karp M, Hershey GK, Malik P.

J Clin Invest. 2016 Feb;126(2):571-84. doi: 10.1172/JCI77250. Epub 2015 Dec 21.

16.

Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.

Anea CB, Lyon M, Lee IA, Gonzales JN, Adeyemi A, Falls G, Kutlar A, Brittain JE.

Am J Hematol. 2016 Feb;91(2):173-8. doi: 10.1002/ajh.24224.

17.

The Acute Chest Syndrome in Cameroonian children living with sickle cell disease.

Nansseu JR, Alima Yanda AN, Chelo D, Tatah SA, Mbassi Awa HD, Seungue J, Koki PO.

BMC Pediatr. 2015 Sep 21;15:131. doi: 10.1186/s12887-015-0454-0.

18.

Inflammatory targets of therapy in sickle cell disease.

Owusu-Ansah A, Ihunnah CA, Walker AL, Ofori-Acquah SF.

Transl Res. 2016 Jan;167(1):281-97. doi: 10.1016/j.trsl.2015.07.001. Epub 2015 Jul 11. Review.

19.

An unexpected full neurological recovery after cardiac arrest in a sickle cell anemia patient with bilateral cervical carotid artery disease.

Martins AC, Silva GS, Adegoke SA, Rodrigues DL, Braga JA, Figueiredo MS.

Rev Bras Hematol Hemoter. 2015 Jul-Aug;37(4):272-4. doi: 10.1016/j.bjhh.2015.04.003. Epub 2015 May 18. No abstract available.

20.

Red blood cell storage duration is not associated with clinical outcomes for acute chest syndrome in children with sickle cell disease.

Fields ME, Hulbert ML, Chen L, Berlin AN, Jackups R, Spinella PC.

Transfusion. 2015 Nov;55(11):2714-21. doi: 10.1111/trf.13176. Epub 2015 May 30.

Supplemental Content

Support Center